Updated:
GRI Bio, Inc.
GRI Bio, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001824293, and its reported industry is...
Overview
GRI Bio, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001824293, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2026-01-30, it reported net income of USD -11,956,000; total assets of USD 8,666,000 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- GRI Bio, Inc.
- Former names in filing history
- Vallon Pharmaceuticals, Inc. (2020-09-11 to 2023-04-21)
- Classification
- Public company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- La Jolla, CA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- Ticker
- Nasdaq: GRI
- SEC CIK
- 0001824293
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2025USD | -$12.0M | $8.7M | $8.2M | -$10.2M | |
| FY2024USD | -$8.2M | $5.7M | $5.0M | -$8.6M | |
| FY2023USD | -$13.0M | $3.0M | $1.8M | -$9.0M | |
| FY2022USD | -$7.0M | $4.2M | $3.8M | -$7.1M |
FY2022. Net income, Total assets, Cash and equivalents, Operating cash flow: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| DEF 14A | DEF 14A | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research GRI Bio, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.